GramEye
PrivateLast Round
Series B
Nov 21, 2025
Total Funding Raised
$6.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GramEye is a medical technology company that develops an AI and robotics solution to automate Gram staining, aiming to facilitate the appropriate use of antimicrobials.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotech Equipment, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GramEye Comparables
Compare GramEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomend | 71% | |
| bioMérieux | 70% | |
| Bruker | 69% |
GramEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 21, 2025 | ||||
| Series A | Oct 13, 2023 |
Key People
Founding team and executive leadership
GramEye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DEEPCORE Inc. | Series A |
| Ikeda Senshu Capital | Series A |
| Samurai Incubate Inc. | Series A, Series B |
| NES Inc. | Series A, Series B |
| Beyond Next Ventures | Series B |
| STATION Ai Corporation | Series A |
| SMBC Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 46% MoM, reaching 6K.
- Apr 18, 2026
Monthly visitors increased 55% MoM.
GramEye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GramEye's valuation, stock price, and market status.
Is GramEye a public or private company?
GramEye is a private company.
What is the current stock price of GramEye?
GramEye is a private company with no public stock price. No recent secondary market data is available.
How much is GramEye worth (valuation)?
Valuation information for GramEye is not publicly available.
Can I buy GramEye stock?
GramEye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GramEye's last funding round?
GramEye's most recent funding round was Series B on November 21, 2025.
Who are the main investors in GramEye?
Key investors in GramEye include Beyond Next Ventures.
Will GramEye IPO soon?
No public IPO plans have been announced for GramEye.
How can I track GramEye secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GramEye's secondary market activity and sign up for updates.